Addressing Patient Concerns and Protecting Their Rights Patient concerns are common during clinical trials, and it is essential that these concerns are acknowledged and addressed promptly
Your skin needs to repair its barrier and calm inflammation without interference from active ingredients
Peer review Peer review information Nature Communications thanks Hongli Mao, and the other, anonymous, reviewer for their contribution to the peer review of this work
The most effective GLP-1 drug for weight loss currently (as of early 2026) is tirzepatide, marketed under the names Zepbound (for weight loss) and Mounjaro (for diabetes)
There were few renal deaths during the trial
Robust proteolytic activity is observed over a 20 minute period in the absence of Axcess excipients, which is completely ablated in their presence (Figure 10A)